Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Surfactants in Lyophilized Products

Posted on By

SOP for Use of Surfactants in Lyophilized Products

Standard Operating Procedure for Use of Surfactants in Lyophilized Products

1) Purpose

This SOP outlines the procedures for incorporating surfactants into lyophilized products to enhance solubility and stability during the lyophilization process and reconstitution.

2) Scope

This SOP applies to all personnel involved in the preparation of lyophilized formulations that require the use of surfactants, including formulation scientists and operators.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting the appropriate surfactant for the formulation.
  • Operators: Responsible for incorporating the surfactant according to the Batch Manufacturing Record (BMR).
  • QA: Responsible for verifying the surfactant addition and maintaining records.
See also  Lyophilized Products : SOP for Preparation of Lyophilized Allergen Extracts

4) Procedure

4.1 Selection of Surfactants

4.1.1 Criteria for Selection

  • 4.1.1.1 The surfactant should be compatible with the formulation and should not interfere with the active ingredient’s stability or efficacy.
  • 4.1.1.2 Commonly used surfactants include polysorbates (Tween 80, Tween 20) and poloxamers (Pluronic F68).

4.2 Incorporation of Surfactants

4.2.1 Weighing and Addition

  • 4.2.1.1 Weigh the surfactant according to the formulation requirements in the BMR.
  • 4.2.1.2 Add the surfactant slowly into the formulation solution while stirring to avoid foaming and ensure uniform distribution.

4.2.2 Mixing and Homogenization

  • 4.2.2.1 Stir the solution using a mechanical stirrer until the surfactant is fully dissolved and evenly distributed in the solution.
  • 4.2.2.2 Homogenize the mixture if required to ensure uniformity at the molecular level.
See also  SOP for Formulation Optimization for Lyophilized Proteins

4.3 Documentation

All steps involving surfactant addition, including weights and batch numbers, must be documented in the Surfactant Addition Logbook and verified by QA.

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Surfactant Addition Logbook

7) References

  • Pharmacopoeial guidelines on the use of surfactants in pharmaceutical formulations

8) SOP Version

Version 1.0

Annexure

Surfactant Addition Logbook Template

Date Surfactant Name Batch No. Quantity Operator Initials QA Verification
DD/MM/YYYY Surfactant Name Batch Number Quantity (grams) Operator Name QA Initials
           


Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: Nanoparticle Formulation : SOP for Preparation of Liposomal Nanoparticles
Next Post: SOP for Development of Powdered Nasal Formulations

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version